These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2462455)

  • 1. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.
    Lucas A; Morley R; Cole TJ
    BMJ; 1988 Nov; 297(6659):1304-8. PubMed ID: 2462455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Moderate hypoglycemia in the preterm infant: is it relevant?].
    Wayenberg JL; Pardou A
    Arch Pediatr; 2008 Feb; 15(2):153-6. PubMed ID: 18206357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate neonatal hypoglycemia and adverse neurological development at 2-6 years of age.
    Wickström R; Skiöld B; Petersson G; Stephansson O; Altman M
    Eur J Epidemiol; 2018 Oct; 33(10):1011-1020. PubMed ID: 30030683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental Outcome of Asymptomatic Hypoglycemia Compared With Symptomatic Hypoglycemia and Euglycemia in High-Risk Neonates.
    Mahajan G; Mukhopadhyay K; Attri S; Kumar P
    Pediatr Neurol; 2017 Sep; 74():74-79. PubMed ID: 28739364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of neurodevelopmental impairment for outborn extremely preterm infants in an Australian regional network.
    Mahoney K; Bajuk B; Oei J; Lui K; Abdel-Latif ME;
    J Matern Fetal Neonatal Med; 2017 Jan; 30(1):96-102. PubMed ID: 26957041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
    Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
    BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection.
    Stoll BJ; Hansen NI; Adams-Chapman I; Fanaroff AA; Hintz SR; Vohr B; Higgins RD;
    JAMA; 2004 Nov; 292(19):2357-65. PubMed ID: 15547163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periventricular intraparenchymal cystic lesions: critical determinant of neurodevelopmental outcome in preterm infants.
    Zorzi C; Angonese I; Zaramella P; Benini F; Dalla Barba B; Cavedagni M; Melli R; De Carolis G
    Helv Paediatr Acta; 1988 Nov; 43(3):195-202. PubMed ID: 2464559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey.
    van de Bor M; van Zeben-van der Aa TM; Verloove-Vanhorick SP; Brand R; Ruys JH
    Pediatrics; 1989 Jun; 83(6):915-20. PubMed ID: 2471139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants.
    Woodward LJ; Anderson PJ; Austin NC; Howard K; Inder TE
    N Engl J Med; 2006 Aug; 355(7):685-94. PubMed ID: 16914704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between neontal morbidity, gestational age and developmental delays in moderate to late preterm children].
    Schonhaut L; Pérez M; Muñoz S
    Rev Chil Pediatr; 2015; 86(6):415-25. PubMed ID: 26471315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Neurodevelopmental Outcome of Preterm Babies Using Risk Stratification Score.
    Sujatha R; Jain N
    Indian J Pediatr; 2016 Jul; 83(7):640-4. PubMed ID: 26916889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcome at 2 years in 23 to 26 weeks old gestation infants.
    Sommer C; Urlesberger B; Maurer-Fellbaum U; Kutschera J; Müller W
    Klin Padiatr; 2007; 219(1):23-9. PubMed ID: 16586271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants.
    Schlapbach LJ; Aebischer M; Adams M; Natalucci G; Bonhoeffer J; Latzin P; Nelle M; Bucher HU; Latal B;
    Pediatrics; 2011 Aug; 128(2):e348-57. PubMed ID: 21768312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological chorioamnionitis and neurodevelopmental outcome in preterm infants.
    Soraisham AS; Trevenen C; Wood S; Singhal N; Sauve R
    J Perinatol; 2013 Jan; 33(1):70-5. PubMed ID: 22555781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcome of hypoglycaemia in healthy, large for gestational age, term newborns.
    Brand PL; Molenaar NL; Kaaijk C; Wierenga WS
    Arch Dis Child; 2005 Jan; 90(1):78-81. PubMed ID: 15613521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPREMO: a prospective cohort study of preterm infant brain structure and function to predict neurodevelopmental outcome.
    George JM; Boyd RN; Colditz PB; Rose SE; Pannek K; Fripp J; Lingwood BE; Lai MM; Kong AH; Ware RS; Coulthard A; Finn CM; Bandaranayake SE
    BMC Pediatr; 2015 Sep; 15():123. PubMed ID: 26377791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological changes in the nervous system in severe neonatal hypoglycaemia.
    Anderson JM; Milner RD; Strich SJ
    Lancet; 1966 Aug; 2(7459):372-5. PubMed ID: 4161723
    [No Abstract]   [Full Text] [Related]  

  • 20. Tractography of white-matter tracts in very preterm infants: a 2-year follow-up study.
    De Bruïne FT; Van Wezel-Meijler G; Leijser LM; Steggerda SJ; Van Den Berg-Huysmans AA; Rijken M; Van Buchem MA; Van Der Grond J
    Dev Med Child Neurol; 2013 May; 55(5):427-33. PubMed ID: 23441853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.